The U.S. Department of Health and Human Services (HHS) analyzes the benefits, costs, and other impacts of significant proposed and final rulemakings, consistent with the requirements of several executive orders and statutes. HHS develops these analyses according to technical guidance published by the U.S.
Benefit-Cost Analysis
Reports
Displaying 1 - 10 of 12. 10 per page. Page 1.
Advanced SearchReport
Guidance on Proper Consideration of Small Entities in Rulemakings of the U.S. Department of Health and Human Services
This guidance, originally published in 2003, contains the following introduction:
Report
The Fiscal Impact of Refugees and Asylees at the Federal, State, and Local Levels from 2005-2019
Between 1990 and 2022, the United States welcomed over 2.1 million refugees and accepted over 800,000 asylees. While the purpose of granting visas to refugees and asylees is humanitarian, they do impact the United States economically. This analysis estimates the fiscal impact of refugees and asylees on federal, state, and local governments from 2005 to 2019.
Report
Addressing Uncertainty in Regulatory Impact Analysis
In 2016, the U.S. Department of Health and Human Services finalized its Guidelines for Regulatory Impact Analysis under the leadership of its Assistant Secretary for Planning Evaluation and Analytics Team. The Guidelines discuss strategies for characterizing the uncertainty in quantified effects as well as the potential impacts of non-quantified effects.
Report
Guidelines for Regulatory Impact Analysis Supplement: Addressing International Effects
This report extends the brief discussion of addressing international effects contained in the Department of Health and Human Service Guidelines for Regulatory Impact Analysis (2016). The purpose of this supplement is to expand that discussion and provide more detailed information on conducting such assessments.
Related Products:
Report
Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses
This report develops an approach for valuing COVID-19 mortality and morbidity risk reductions based on the U.S. Department of Health and Human Services (HHS) Guidelines for Regulatory Impact Analysis. Valuing risk reductions associated with regulations or other policies that address the novel coronavirus disease 2019 (COVID-19) presents major challenges.
Preliminary Cost and Quality Findings from the National Evaluation of the Certified Community Behavioral Health Clinic Demonstration
September 2020
HTML Format (58 PDF pages)
Implementation Findings from the National Evaluation of the Certified Community Behavioral Health Clinic Demonstration
September 2020
Printer Friendly Version in PDF Format (200 PDF pages)
Report to Congress
Certified Community Behavioral Health Clinics Demonstration Program: Report to Congress, 2019
September 2020
Printer Friendly Version in PDF Format (32 PDF pages)
Cost Effectiveness Considerations in the Approval and Adoption of New Health Technologies
Contents Background and Purpose Methodology Summary of Key Findings and Stakeholder Suggestions Conclusions and Policy Implications A.